Literature DB >> 23657176

Neutrophil-to-lymphocyte ratio is associated with severity of coronary artery ectasia.

Bahadir Sarli1, Ahmet Oguz Baktir, Hayrettin Saglam, Huseyin Arinc, Serkan Kurtul, Serdar Sivgin, Mahmut Akpek, Mehmet G Kaya.   

Abstract

We investigated the association between coronary artery ectasia (CAE) and Neutrophil-to-lymphocyte ratio (NLR), an indicator of the inflammatory state. The study population included 434 patients (247 males, mean age 62 ± 10 years) including 230 patients with isolated CAE and 104 patients with coronary artery disease and 100 patientss with normal coronary arteries. The NLR was measured at admission and 30 days after coronary angiography in all the patients. The NLR was significantly higher in patients with CAE than those with normal coronary arteries (2.2 ± 0.6-1.3 ± 0.6, P < .001). Linear regression analyses revealed that NLR (coefficient β = -.61, P < .001) was significantly associated with severity of CAE. The NLR is significantly higher in patients with CAE compared to controls with normal coronary arteries, and NLR is associated with severity of CAE.

Entities:  

Keywords:  coronary artery ectasia; inflammation; neutrophil to lymphocyte ratio

Mesh:

Year:  2013        PMID: 23657176     DOI: 10.1177/0003319713488932

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  9 in total

1.  Usefulness of Immature Granulocytes to Predict High Coronary SYNTAX Score in Acute Coronary Syndrome; a Cross-sectional Study.

Authors:  Cihan Bedel; Mustafa Korkut; Fatih Aksoy; Görkem Kuş
Journal:  Arch Acad Emerg Med       Date:  2020-09-15

Review 2.  Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis.

Authors:  Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Dimitrios Kazantzis; Jorge Sanz-Sánchez; Sotiria G Giotaki; Konstantinos Raisakis; Andreas Kaoukis; Charalampos Kossyvakis; Gerasimos Deftereos; Bernhard Reimers; Dimitrios Avramides; Gerasimos Siasos; Michael Cleman; George Giannopoulos; Alexandra Lansky; Spyridon Deftereos
Journal:  Diagnostics (Basel)       Date:  2022-04-19

3.  Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia.

Authors:  Wei Wei; Xingxu Wang; Zhenghao Huang; Xiaolin Li; Yu Luo
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

4.  Usefulness of Neutrophil to Lymphocyte Ratio in Prediction of Coronary Artery Lesions in Patients with Kawasaki Disease.

Authors:  Fikri Demir; Cem Karadeniz; Rahmi Özdemir; Yılmaz Yozgat; Kübra Çelegen; Utku Karaaslan; Mustafa Demirol; Timur Meşe; Nurettin Ünal
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

5.  The Relationship Between Blood Monocyte Count and Coronary Artery Ectasia.

Authors:  Mehmet Demir; Canan Demir; Serdar Keceoglu
Journal:  Cardiol Res       Date:  2014-10-06

6.  Relationship between platelet-to-lymphocyte ratio and the presence and severity of coronary artery ectasia.

Authors:  Harun Kundi; Murat Gök; Mustafa Çetin; Emrullah Kızıltunç; Hülya Çiçekcioğlu; Zehra Güven Çetin; Orhan Karayiğit; Ender Örnek
Journal:  Anatol J Cardiol       Date:  2016-04-21       Impact factor: 1.596

7.  Hypertension and coronary artery ectasia: a systematic review and meta-analysis study.

Authors:  Mostafa Bahremand; Ehsan Zereshki; Behzad Karami Matin; Mansour Rezaei; Hamidreza Omrani
Journal:  Clin Hypertens       Date:  2021-07-15

8.  Determinants of endothelial dysfunction in patients with non-alcoholic steatohepatitis.

Authors:  Bahadir Sarli; Huseyin Arinc; Ahmet Oguz Baktir; Hayrettin Saglam; Erkan Demirci
Journal:  Ups J Med Sci       Date:  2013-11-18       Impact factor: 2.384

Review 9.  Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.

Authors:  Sai Zhang; Jun Diao; Chunmei Qi; Jingjing Jin; Li Li; Xingjuan Gao; Lei Gong; Weiheng Wu
Journal:  BMC Cardiovasc Disord       Date:  2018-05-02       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.